HemOnc Today Current Issue
The following articles appeared in the print edition of HemOnc Today.
Table of Contents
- The cost of health care: Current expenditures unsustainable
-
- Combining oblimersen with fludarabine/cyclophosphamide improved survival in CLL
- Concomitant use of chemotherapy, bevacizumb safe in NSCLC with treated brain metastases
- Is explicit rationing of health care inevitable in the United States?
- Meta-analysis: D-dimer excluded VTE in outpatients
- Minimally invasive endoscopic treatment as effective as surgery for esophageal cancer
- Oral contraceptives still linked to increased venous thrombosis risk
- Otamixaban reduced major coronary complications in acute coronary syndrome
- Patients traveling farther for esophageal, pancreatic surgical cancer care
-
- Paul Ness, MD, blood transfusion specialist discusses his love of Maine, literature and music
- Stanford V as efficacious as ABVD when combined with radiotherapy in advanced HL
- TRIANA: Primary PCI comparable to thrombolysis for reperfusion in elderly patients
- Two umbilical cord blood transplants lowered relapse risk in acute leukemias
- 36-year-old man with abdominal pain and retroperitoneal lymphadenopathy Anne Blaes, MD, MS
- Is the recent concern over insulin glargine and malignancy warranted? Derek LeRoith, MD, PhD
- Pigmented villonodular synovitis in a patient with prior history of breast cancer Munir Ghesani, MD, FACNM; Gabriel Sara, MD; Carlos Benitez, MD; Irene Dy, MD
- Physical activity can be a supportive intervention for cancer patients Christine A. Zawistowski, MD
-